These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25205820)

  • 21. Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets.
    Blachier F; Mourtada A; Sener A; Malaisse WJ
    Endocrinology; 1989 Jan; 124(1):134-41. PubMed ID: 2462484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of the inhibitory G-protein Galphai2 predisposes to ventricular cardiac arrhythmia.
    Zuberi Z; Nobles M; Sebastian S; Dyson A; Lim SY; Breckenridge R; Birnbaumer L; Tinker A
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):391-400. PubMed ID: 20495013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gbetagamma-activated inwardly rectifying K(+) (GIRK) channel activation kinetics via Galphai and Galphao-coupled receptors are determined by Galpha-specific interdomain interactions that affect GDP release rates.
    Zhang Q; Dickson A; Doupnik CA
    J Biol Chem; 2004 Jul; 279(28):29787-96. PubMed ID: 15123672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulus-secretion coupling of arginine-induced insulin release. Metabolism of L-arginine and L-ornithine in pancreatic islets.
    Malaisse WJ; Blachier F; Mourtada A; Camara J; Albor A; Valverde I; Sener A
    Biochim Biophys Acta; 1989 Sep; 1013(2):133-43. PubMed ID: 2669974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galpha(i2), Galpha(i3)and Galpha(o) are all required for normal muscarinic inhibition of the cardiac calcium channels in nodal/atrial-like cultured cardiocytes.
    Ye C; Sowell MO; Vassilev PM; Milstone DS; Mortensen RM
    J Mol Cell Cardiol; 1999 Sep; 31(9):1771-81. PubMed ID: 10471359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gαi2 signaling: friend or foe in cardiac injury and heart failure?
    Kaur K; Parra S; Chen R; Charbeneau RA; Wade SM; Jay PY; Neubig RR
    Naunyn Schmiedebergs Arch Pharmacol; 2012 May; 385(5):443-53. PubMed ID: 22411356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous desensitization of insulin secretion by GIP (glucose-dependent insulinotropic peptide) in INS-1 cells: the significance of Galphai2 and investigations on the mechanism involved.
    Rucha A; Verspohl EJ
    Cell Biochem Funct; 2005; 23(3):205-12. PubMed ID: 15376236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.
    Thompson BD; Jin Y; Wu KH; Colvin RA; Luster AD; Birnbaumer L; Wu MX
    J Biol Chem; 2007 Mar; 282(13):9547-9555. PubMed ID: 17289675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity.
    Bonomi L; Brown M; Ungerleider N; Muse M; Matzuk MM; Schneyer A
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E587-96. PubMed ID: 22739106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Galphai1 and Galphai3 differentially interact with, and regulate, the G protein-activated K+ channel.
    Ivanina T; Varon D; Peleg S; Rishal I; Porozov Y; Dessauer CW; Keren-Raifman T; Dascal N
    J Biol Chem; 2004 Apr; 279(17):17260-8. PubMed ID: 14963032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3.
    Lane JR; Powney B; Wise A; Rees S; Milligan G
    Mol Pharmacol; 2007 May; 71(5):1349-59. PubMed ID: 17287401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRPM5 regulates glucose-stimulated insulin secretion.
    Brixel LR; Monteilh-Zoller MK; Ingenbrandt CS; Fleig A; Penner R; Enklaar T; Zabel BU; Prawitt D
    Pflugers Arch; 2010 Jun; 460(1):69-76. PubMed ID: 20393858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor-induced inflammatory cytokines are suppressed by gain of function or overexpression of Gα(i2) protein.
    Li P; Neubig RR; Zingarelli B; Borg K; Halushka PV; Cook JA; Fan H
    Inflammation; 2012 Oct; 35(5):1611-7. PubMed ID: 22581266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age increases cardiac Galpha(i2) expression, resulting in enhanced coupling to G protein-coupled receptors.
    Kilts JD; Akazawa T; Richardson MD; Kwatra MM
    J Biol Chem; 2002 Aug; 277(34):31257-62. PubMed ID: 12065589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion.
    Regard JB; Kataoka H; Cano DA; Camerer E; Yin L; Zheng YW; Scanlan TS; Hebrok M; Coughlin SR
    J Clin Invest; 2007 Dec; 117(12):4034-43. PubMed ID: 17992256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion.
    Ma YH; Landis C; Tchao N; Wang J; Rodd G; Hanahan D; Bourne HR; Grodsky GM
    Endocrinology; 1994 Jan; 134(1):42-7. PubMed ID: 7506212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals.
    Baritono E; Ceolotto G; Papparella I; Sartori M; Ciccariello L; Iori E; Calò L; Pessina AC; Semplicini A
    J Hypertens; 2004 Apr; 22(4):783-92. PubMed ID: 15126921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms involved in the effect of nitric oxide synthase inhibition on L-arginine-induced insulin secretion.
    Gross R; Roye M; Manteghetti M; Broca C; Hillaire-Buys D; Masiello P; Ribes G
    Br J Pharmacol; 1997 Feb; 120(3):495-501. PubMed ID: 9031755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.